Breast lumps secondary prevention

Revision as of 20:55, 19 December 2018 by Shadan Mehraban (talk | contribs)
Jump to navigation Jump to search

Breast lumps Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Breast lumps from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Breast lumps secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Breast lumps secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Breast lumps secondary prevention

on Breast lumps secondary prevention

Breast lumps secondary prevention in the news

Blogs on Breast lumps secondary prevention

Directions to Hospitals Treating Breast lumps

Risk calculators and risk factors for Breast lumps secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Secondary prevention of breast lumps is the same as primary prevention [1].

  • Surveillance and follow-up to reduce breast cancer reccurance[2]
    • History and clinical physical examination required every 4 to 6 months for 5 years
    • Annual mammography and clinical physical examination after first 5 years
    • Annual gynecological assessment for uterus evaluation for women on tamoxifen
    • Bone health assessment for women on aromatase inhibitor and those who had ovarian failure secondary to treatment
    • Establishment of physical activity, alcohol intake, weight gain



References

  1. Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B; et al. (2017). "Primary and secondary prevention of breast cancer". Ann Agric Environ Med. 24 (4): 549–553. doi:10.26444/aaem/75943. PMID 29284222.
  2. de Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ (2004). "Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review". J Clin Oncol. 22 (19): 4010–8. doi:10.1200/JCO.2004.06.080. PMID 15459225.


Template:WikiDoc Sources